Expiration date: 06/2027

The composition and form of issue:

Tablets, film-coated. 1 tablet contains the active ingredient

ossein microcrystalline hydroxyapatite compound 830 mg

(refers to the dry substance) corresponding to:

ossein is about 291 mg

consisting of: 

not collagen peptides/proteins 75 mg

collagens 216 mg

calcium hydroxyphosphate (hydroxyapatite) of about 444 mg

including: 

calcium 178 mg

phosphorus 82 mg

the inactive organic fraction of OGS about 95 mg

(consisting of lipids, citric acid, glycosaminoglycan carbonates in various proportions depending on the particular party animal raw materials) 

other ingredients: microcrystalline cellulose silicon dioxide colloidal magnesium stearate starch-potato 

shell: titanium dioxide talc iron oxide yellow hypromellose 

blistere in 10 PCs., in box 4 blisters.

Pharmacological action:

Activates the formation of bone tissue.

Indications:

Primary osteoporosis (pre-, peri - and postmenopausal, senile), secondary (due to use of glucocorticoids, heparin, immobilisation, rheumatoid arthritis, diseases of the liver and kidneys, hyperthyroidism and hyperparathyroidism, imperfect bone formation), osteoporosis (treatment and prevention) violation of calcium-phosphorus balance during pregnancy and lactation bone fractures (to accelerate healing).

Contraindications:

Hypersensitivity, hypercalcemia, hypercalciuria.

Method of application and dose:

Inside. Osteoporosis — table 2-4. 2 times a day. Other indications — 1-2 table. a day.

Precautions:

In patients predisposed to kidney stones, dose adjustment is necessary. When renal dysfunction should avoid prolonged use of large doses.